MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients

Conclusion: A predictive miRNA associated with progression-free survival in metastatic renal cell carcinoma patients treated with sunitinib was identified.

Source: Cancer Genomics and Proteomics - August 28, 2019 Category: Cancer & Oncology Authors: KOVACOVA, J., JURACEK, J., POPRACH, A., KOPECKY, J., FIALA, O., SVOBODA, M., FABIAN, P., RADOVA, L., BRABEC, P., BUCHLER, T., SLABY, O. Tags: Article Source Type: research